Scholarlink

Purpose <p>The present study was conducted to evaluate the effect of using ozone gel with transcrestal sinus floor elevation on the clinical and radiographic outcome of implants placed simultaneously.</p> Materials and Methods <p>A total of 30 sinuses with an average residual alveolar bone height ranging from 4 to 7&#xa0;mm participated in this randomized controlled clinical trial. After transcrestal sinus floor elevation operation, patients were randomly and equally allocated into control group where transcrestal sinus floor elevation “TSFE” with simultaneous implant placement were done and ozone gel recipient group where ozone gel was placed in the osteotomy site after TSFE and prior to implant placement. Cone beam computed tomography was performed immediately and at 4&#xa0;months postoperatively. Bone stability was measured immediately and at 3 &amp; 4&#xa0;months postoperatively. Bone height and stability were evaluated radiographically, and bone stability was measured using the Osstell device.</p> Results <p>Radiographic analysis revealed that the mean bone height of the control group after four months postoperative was 11.09 ± 0.86&#xa0;mm compared to 10.73 ± 0.65&#xa0;mm in the study group, which was statistically insignificant (P &gt; 0.05). The mean bone density value of the control group four months after surgery was 272.3 ± 119.1&#xa0;Gy values compared to 363.6 ± 178.6&#xa0;Gy values in the study group. Although the bone density in the study group was higher than the control group, it was statistically insignificant (P &gt; 0.05). The mean ISQ value after 4&#xa0;months in the ozone gel group was 86.7 ± 6.7 compared to 86.4 ± 3.7 in the control group, which was statistically non-significant.</p> Conclusion <p>Ozone gel recipient group showed non-significant results in terms of the bone height and implant stability as compared to graftless tenting technique. However, it showed better but also non-significant results in terms of bone density. Therefore, both techniques showed accepted results.</p> Trial Registration <p>This study protocol was retrospectively registered on the trial registry “Clinical trials.gov PRS”. ClinicalTrials.gov ID is: NCT06604819 and the registration date is 20/9/2024.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The Impact of Ozone Gel on the Implant Stability and Bone Measurements After Transcrestal Sinus Floor Elevation with Simultaneous Implant Placement: A Randomized Controlled Clinical Trial

  • 期刊论文

  • 发表日期：

    2026年4月29日

查看全文
  • Dina Yousry,
  • Raafat Riad,
  • Rehab A. Soliman,
  • Mohamed ElSholkamy

摘要

Purpose

The present study was conducted to evaluate the effect of using ozone gel with transcrestal sinus floor elevation on the clinical and radiographic outcome of implants placed simultaneously.

Materials and Methods

A total of 30 sinuses with an average residual alveolar bone height ranging from 4 to 7 mm participated in this randomized controlled clinical trial. After transcrestal sinus floor elevation operation, patients were randomly and equally allocated into control group where transcrestal sinus floor elevation “TSFE” with simultaneous implant placement were done and ozone gel recipient group where ozone gel was placed in the osteotomy site after TSFE and prior to implant placement. Cone beam computed tomography was performed immediately and at 4 months postoperatively. Bone stability was measured immediately and at 3 & 4 months postoperatively. Bone height and stability were evaluated radiographically, and bone stability was measured using the Osstell device.

Results

Radiographic analysis revealed that the mean bone height of the control group after four months postoperative was 11.09 ± 0.86 mm compared to 10.73 ± 0.65 mm in the study group, which was statistically insignificant (P > 0.05). The mean bone density value of the control group four months after surgery was 272.3 ± 119.1 Gy values compared to 363.6 ± 178.6 Gy values in the study group. Although the bone density in the study group was higher than the control group, it was statistically insignificant (P > 0.05). The mean ISQ value after 4 months in the ozone gel group was 86.7 ± 6.7 compared to 86.4 ± 3.7 in the control group, which was statistically non-significant.

Conclusion

Ozone gel recipient group showed non-significant results in terms of the bone height and implant stability as compared to graftless tenting technique. However, it showed better but also non-significant results in terms of bone density. Therefore, both techniques showed accepted results.

Trial Registration

This study protocol was retrospectively registered on the trial registry “Clinical trials.gov PRS”. ClinicalTrials.gov ID is: NCT06604819 and the registration date is 20/9/2024.